Remote Jobs at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

201 - 500 employees

Founded 2016

🧬 Biotechnology

💊 Pharmaceuticals

💰 $150M Post-IPO Equity - Arcutis Biotherapeutics on 2024-02

Biotechnology • Pharmaceuticals

Arcutis Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing meaningful innovations in medical dermatology, particularly topical immuno-dermatology therapies for chronic, immune-mediated skin diseases. Founded in 2016 and traded on Nasdaq (ARQT), Arcutis has advanced products including ZORYVE (roflumilast) cream and foam and a pipeline (e. g. , ARQ-234) targeting indications such as plaque psoriasis, atopic dermatitis, seborrheic dermatitis, scalp psoriasis, vitiligo, and hidradenitis suppurativa. The company emphasizes patient- and physician-focused development, topical formulation expertise, and commercialization of FDA-approved and investigational dermatology treatments.